Drug Profile
Research programme: anaemia therapeutics - Palkion
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator CrystalGenomics; Palkion
- Developer Palkion
- Class DNA-binding proteins
- Mechanism of Action Procollagen-proline dioxygenase modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Anaemia